We are live on ! Find out more
TCM

Triumph Capital Management Portfolio holdings

AUM $552M
1-Year Est. Return 20.75%
This Fund
S&P 500
This Quarter Est. Return
+1.33%
1 Year Est. Return
+20.75%
3 Year Est. Return
+48.64%
5 Year Est. Return
+27.72%
10 Year Est. Return
AUM
$463M
AUM Growth
+$90M
Cap. Flow
+$87.6M
Cap. Flow %
18.93%
Top 10 Hldgs %
21.74%
Holding
1,776
New
1,457
Increased
139
Reduced
167
Closed
7

Sector Composition

Rank Sector Weight
1 Technology 10.28%
2 Financials 8.08%
3 Consumer Discretionary 3.76%
4 Healthcare 1.81%
5 Communication Services 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRL icon
1526
Charles River Laboratories
CRL
$12.8B
$1.4K ﹤0.01%
+7
New +$1.27K
GNTX icon
1527
Gentex
GNTX
$5.07B
$1.4K ﹤0.01%
+60
New +$1.45K
HELO icon
1528
JPMorgan Hedged Equity Laddered Overlay ETF
HELO
$4.72B
$1.4K ﹤0.01%
+21
New +$1.38K
FLEX icon
1529
Flex
FLEX
$44.8B
$1.39K ﹤0.01%
+23
New +$1.42K
PXH icon
1530
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
$1.34K ﹤0.01%
+52
New +$1.34K
USAI icon
1531
Pacer American Energy Infrastructure ETF
USAI
$129M
$1.33K ﹤0.01%
+35
New +$1.33K
BSM icon
1532
Black Stone Minerals
BSM
$3B
$1.33K ﹤0.01%
+100
New +$1.35K
VFVA icon
1533
Vanguard US Value Factor ETF
VFVA
$914M
$1.33K ﹤0.01%
+10
New +$1.29K
GTBP icon
1534
GT Biopharma
GTBP
$11.5M
$1.3K ﹤0.01%
+1,655
New +$1.18K
ONEZ
1535
TrueShares Seasonality Laddered Buffered ETF
ONEZ
$346M
$1.3K ﹤0.01%
+50
New +$1.34K
APTV icon
1536
Aptiv
APTV
$10.3B
$1.29K ﹤0.01%
+17
New +$1.36K
NVCR icon
1537
NovoCure
NVCR
$1.91B
$1.29K ﹤0.01%
+100
New +$1.28K
DOX icon
1538
Amdocs
DOX
$6.22B
$1.29K ﹤0.01%
+16
New +$1.29K
KD icon
1539
Kyndryl
KD
$3.05B
$1.27K ﹤0.01%
+48
New +$1.3K
LDOS icon
1540
Leidos
LDOS
$17.3B
$1.26K ﹤0.01%
+7
New +$1.33K
ALGS icon
1541
Aligos Therapeutics
ALGS
$34.9M
$1.26K ﹤0.01%
+135
New +$1.27K
CHIQ icon
1542
Global X MSCI China Consumer Discretionary ETF
CHIQ
$127M
$1.25K ﹤0.01%
+59
New +$1.33K
CRH icon
1543
CRH
CRH
$66.8B
$1.25K ﹤0.01%
+10
New +$1.19K
DD icon
1544
DuPont de Nemours
DD
$19.2B
$1.25K ﹤0.01%
+10
New +$1.13K
BKUI icon
1545
BNY Mellon Ultra Short Income ETF
BKUI
$581M
$1.24K ﹤0.01%
+25
New +$1.25K
RBA icon
1546
RB Global
RBA
$17.5B
$1.23K ﹤0.01%
+12
New +$1.22K
EA
1547
DELISTED
Electronic Arts
EA
$1.23K ﹤0.01%
+6
New +$1.21K
UNG icon
1548
United States Natural Gas Fund
UNG
$455M
$1.23K ﹤0.01%
+100
New +$1.35K
USFD icon
1549
US Foods
USFD
$24B
$1.21K ﹤0.01%
+16
New +$1.2K
UAUG icon
1550
Innovator US Equity Ultra Buffer ETF August
UAUG
$165M
$1.2K ﹤0.01%
+30
New +$1.19K

Similar funds

Triumph Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Triumph Capital Management held 1,776 positions worth $463M, up 24% from $373M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Triumph Capital Management deployed $87.6M of net new capital in Q4 2025, opening 1,457 new positions and adding to 139 existing holdings. Its largest new stake was Dimensional Short-Duration Fixed Income ETF: 150,385 shares worth $7.21M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.8% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Innovator US Equity Ultra Buffer ETF December, an estimated $4.19M trimmed.

  • Triumph Capital Management's largest Q4 2025 buy was Dimensional Short-Duration Fixed Income ETF: 150,385 shares worth $7.21M.
  • Triumph Capital Management added most to Apple in Q4 2025, an estimated $12.7M increase.
  • Triumph Capital Management's biggest Q4 2025 reduction was Innovator US Equity Ultra Buffer ETF December, cutting an estimated $4.19M.
  • Triumph Capital Management fully exited Covista Inc in Q4 2025, selling an estimated $496K.
  • Triumph Capital Management's ten largest holdings make up 22% of its $463M portfolio in Q4 2025.
  • Triumph Capital Management opened 1,457 new positions and closed 7 in Q4 2025.
  • Triumph Capital Management's portfolio value rose 24% quarter-over-quarter to $463M.

Based on Triumph Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.